text: <unk>  is a glucagon-like peptide 1 (GLP-1) receptor agonist that is FDA approved for the adjunction of diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include nausea, vomiting, diarrhea, abdominal pain and constipation.
option_0: Semaglutide
option_1: Albiglutide
option_2: Teduglutide
option_3: Dulaglutide
option_4: Liraglutide
option_5: Linagliptin
option_6: Exenatide
option_7: Saxagliptin